EUVIMEDEUVIMED entdecken
Crossref

Association between socioeconomic position and discontinuation of pharmacotherapy for heart failure after cardiac resynchronization therapy

Maria Hee Jung Park Frausing iD, Christoffer Tobias Witt iD, István Bakos iD, Erzsébet Horváth-Puhó iD, Brian Bridal Løgstrup iD, Hans Eiskjær iD, Jens Cosedis Nielsen iD, Rikke Elmose Mols iD

European Journal of Cardiovascular Nursing · 2024

DOI: 10.1093/eurjcn/zvae083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardiovascular Nursing, 2024. Verfasst von Maria Hee Jung Park Frausing und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Bvld. 99, 8200 Aarhus N, Denmark. Hauptthemen laut MEDLINE: Heart Failure, Cardiac Resynchronization Therapy, Registries, Angiotensin-Converting Enzyme Inhibitors. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Karen Elise Jensen Foundation, Helse Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pharmacological therapy remains a cornerstone in heart failure (HF) treatment despite the implantation of a cardiac resynchronization therapy (CRT) device. The aim of this study was to investigate the association between (i) drug discontinuation and (ii) long-term adherence to HF pharmacotherapy after CRT implantation and socioeconomic position and multimorbidity. Methods and results We conducted a registry-based cohort study including all patients who underwent a first-time CRT implantation at Aarhus University Hospital from 2000 to 2017. Heart failure pharmacotherapy included beta-blockers (BBs), renin–angiotensin system inhibitors [angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB)], and mineralocorticoid receptor antagonists (MRAs). Patients were identified using the Danish Pacemaker and International Classification for Disease Registry, and information about medication and comorbidities was obtained through linkage to the Danish health registries. We identified 2007 patients, of whom 1880 (94%) were eligible for inclusion. The cumulative incidence of drug discontinuation at 10 years was 6% [95% confidence interval (CI) 5–8%] for BB, 10% (95% CI 9–12%) for ACEI/ARB, and 24% (95% CI 20–27%) for MRAs. Living alone was associated with higher BB discontinuation rates [hazard ratio (HR) 1.83, 95% CI 1.20–2.79], whereas patients with multimorbidity were more likely to discontinue ACEI/ARB (HR 1.92, 95% CI 1.33–2.80) and MRA therapy (HR 1.51, 95% CI 1.10–2.09). Income and educational level did not influence drug discontinuation rates, and similar adherence patterns were observed across all strata of socioeconomic position and multimorbidity.

Conclusion

In patients with CRTs, drug discontinuation rates were low, and adherence to HF pharmacotherapy was comparable regardless of socioeconomic position. Living alone and multimorbidity were associated with the discontinuation of specific HF drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCardiac Resynchronization TherapyRegistriesAngiotensin-Converting Enzyme InhibitorsMineralocorticoid Receptor AntagonistsDrug MonitoringHumansFemaleMaleAgedMiddle AgedDenmarkCohort StudiesAdrenergic beta-AntagonistsAngiotensin Receptor AntagonistsSocioeconomic FactorsAged, 80 and overSocial Class

Stichwörter der Autor:innen

AdherenceCardiac resynchronization therapyHeart failureMedicationPharmacotherapySocioeconomic position

Substanzen

Angiotensin-Converting Enzyme InhibitorsMineralocorticoid Receptor AntagonistsAdrenergic beta-AntagonistsAngiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Bvld. 99, 8200 Aarhus N, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Palle Juul-Jensens Bvld. 82, 8200 Aarhus N, Denmark.
  • Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200 Aarhus N, Denmark.

ORCID-Profile: Maria Hee Jung Park Frausing, Christoffer Tobias Witt, István Bakos, Erzsébet Horváth-Puhó, Brian Bridal Løgstrup, Hans Eiskjær, Jens Cosedis Nielsen, Rikke Elmose Mols

Förderung

  • Karen Elise Jensen Foundation
  • Helse Foundation

Zitieren

APA

Frausing, M. H. J. P., Witt, C. T., Bakos, I., Horváth-Puhó, E., Løgstrup, B. B., Eiskjær, H., Nielsen, J. C., & Mols, R. E. (2024). Association between socioeconomic position and discontinuation of pharmacotherapy for heart failure after cardiac resynchronization therapy. European Journal of Cardiovascular Nursing. https://doi.org/10.1093/eurjcn/zvae083

Vancouver

Frausing MHJP, Witt CT, Bakos I, Horváth-Puhó E, Løgstrup BB, Eiskjær H, et al. Association between socioeconomic position and discontinuation of pharmacotherapy for heart failure after cardiac resynchronization therapy. European Journal of Cardiovascular Nursing. 2024. doi:10.1093/eurjcn/zvae083

BibTeX
@article{Frausing2024,
  author = {Frausing, Maria Hee Jung Park and Witt, Christoffer Tobias and Bakos, István and Horváth-Puhó, Erzsébet and Løgstrup, Brian Bridal and Eiskjær, Hans and Nielsen, Jens Cosedis and Mols, Rikke Elmose},
  title = {Association between socioeconomic position and discontinuation of pharmacotherapy for heart failure after cardiac resynchronization therapy},
  journal = {European Journal of Cardiovascular Nursing},
  year = {2024},
  doi = {10.1093/eurjcn/zvae083}
}
Kostenlos starten →